GHTC Blog Post Discusses U.S., European Efforts To Address Drug Resistance, Speed Treatment Approvals

Global Health Technology Coalition’s “Breakthroughs”: Research Roundup: U.S. and European efforts to address growing antimicrobial resistance and legislation to advance medical breakthroughs
Kat Kelley, GHTC’s senior program assistant, discusses efforts made by the U.S. and European Parliament to address the threat of antimicrobial resistance, as well as “a bill intended to support research for and expedite the approval of medical breakthroughs” (5/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.